Structure−Activity Analysis of Anandamide Analogs: Relationship to a Cannabinoid Pharmacophore-Reference-Cited by-同舟云学术

Structure−Activity Analysis of Anandamide Analogs: Relationship to a Cannabinoid Pharmacophore

Published:1996-01-01 Issue:2 Volume:39 Page:471-479
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Thomas Brian F.¹,Adams Irma B.¹,Mascarella S. Wayne¹,Martin Billy R.¹,Razdan Raj K.¹

Affiliation:

1. Research Triangle Institute, Research Triangle Park, North Carolina 27709, Medical College of Virginia/Virginia Commonwealth University, Richmond, Virginia 23298, and Organix, Inc., Woburn, Massachusetts 01801

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm9505167

Reference27 articles.

1. Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor

2. Anandamide, a Brain Endogenous Compound, Interacts Specifically with Cannabinoid Receptors and Inhibits Adenylate Cyclase

3. Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modeling cannabis and Catha edulis bioactives and derivatives: insights from computational and theoretical predictions;Cannabis and Khat in Drug Discovery;2024

2. N-eicosapentaenoyl-ethanolamine decreases the proliferation of psoriatic keratinocytes in a reconstructed psoriatic skin model;Scientific Reports;2023-07-26

3. Theoretical Study of the Structural, Nmr and IR Spectroscopic, and Electronic Properties of the Preferred Conformations of Neurotransmitter Anandamide;SSRN Electronic Journal;2022

4. Understanding the conformational, electronic and vibrational properties of Tetrahydrocannabinol (THC) and Cannabidiol (CBD). Pharmacophoric similarities and differences;Journal of Molecular Structure;2021-11

5. Emerging class of omega-3 fatty acid endocannabinoids & their derivatives;Prostaglandins & Other Lipid Mediators;2019-08